On April 17, DAMO PANDA, an artificial intelligence model designed for pancreatic cancer screening by Alibaba's DAMO Academy, was honored as a 'Breakthrough Medical Device' by the Food and Drug Administration (FDA). This innovative model excels at precisely detecting subtle abnormalities in standard CT scans, addressing a significant global hurdle in the early detection of pancreatic cancer. This accolade signifies the first instance where a prominent Chinese technology firm has received such prestigious international approval.
